Please select the option that best describes you:
Topics:
Primary Care • General Primary Care
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
Seminer A, Mulihano A, O’Brien C, et al. Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis. JAMA